MITO SEQUENCING
Evaluation of treatment sequencing in advanced or recurrent endometrial cancer according to MMR status: an open-label, multi cohort phase 2 trial
STATO: Raccolta adesioni in corso
PATOLOGIA: Endometrio
CENTRO COORDINATORE MITO: Humanitas San Pio X, Milano
PRINCIPAL INVESTIGATOR: Domenica Lorusso
CO INVESTIGATOR:
STUDY COORDINATOR:
DOCUMENTAZIONE
RICHIESTE DI ADESIONE
ADESIONI COMPLETE